Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical Registries Need Streamlining To Reap Benefits, Mussallem Tells Congress

This article was originally published in The Gray Sheet

Executive Summary

Clinical registries can yield useful information on patient outcomes that can support approval, reimbursement and care decisions but the benefits of registries need to be balanced against their costs, Edwards Lifesciences CEO Michael Mussalem told a House Energy and Commerce subcommittee July 22.

You may also be interested in...

Health IT Groups Praise Goals Of Draft EHR Bill, But Question Mandates

Electronic health records would have to be coordinated enough for users to view results of patient tests, see registry information, and access device data under a Senate HELP Committee draft bill calling for federal standards, but health IT groups say they would prefer a more voluntary approach.

House Bill Would Tie Electronic Health Records To Clinical Registries

A clinical registries bill passed by the House Energy and Commerce Committee July 30 would call on HHS to recommend how to tie data from patients’ electronic health records into information collected from clinical trials, and on ways to use registries to capture postmarket device data and support device reimbursement.

Adding UDIs To Claims Is Crucial for Device Surveillance, Pew Tells Congress

Incorporating unique device identifiers into insurance claims is necessary to leverage FDA’s Sentinel postmarket surveillance initiative to devices, Josh Rising of The Pew Charitable Trusts emphasized to House lawmakers at a recent hearing.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts